Baxter International Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 04/23/2024

Stock Rating
17
Price Target
$45.00
Consensus
Outperform
Upside
9.70%
Analysts
5
Stock Rating
17
Upside
9.70%
Analysts
5
Price Target
$45.00

Baxter International Inc Stock Forecast and Price Target

Baxter International Inc's most recent price target of $45.00 for 2024 was provided by five renowned analysts over the past few months, with an average prediction of $45.00. If this prediction is correct, Baxter International Inc's stock could rise by 9.7 percent from its current trading price. The potential increase for the stock is $45.00 per share, with a possible range of $39.00 to $67.00. If you're thinking of investing in BAX stock, it might be good to look at its rivals too.

$45.00

9.70% Upside

Outperform
Outperform

Baxter International Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Baxter International Inc has seen a decline in its Price, from $66.00 to $0.00 – a 100.00% decrease. Next year, analysts are expecting Fair Value to reach $117.48 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$117.48
2025 Fair Value Forecast
$129.44
2026 Fair Value Forecast
$140.34
2027 Fair Value Forecast
$94.84
2028 Fair Value Forecast
$119.19
2029 Fair Value Forecast
$127.05
2030 Fair Value Forecast
$136.09
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$745.69 Buy/Sell $636.99 12.31%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$149.56 Buy/Sell $174.55 13.67%
MRK Stock Forecast Merck Outperform 2
$126.88 Buy/Sell $130.51 9.95%
PFE Stock Forecast Pfizer Outperform 2
$26.32 Buy/Sell $32.87 15.88%
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 12
$404.91 Buy/Sell $457.59 11.14%

Baxter International Inc Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Baxter International Inc's Revenue has grown from $11.67B to $14.81B – a 26.90% increase. Next year, analysts are expecting Revenue to reach $17.41B – an increase of 17.56%. Over the next seven years, the forecast is for Revenue to grow by 24.69%.

2024 Rev Forecast
$17.41B
2025 Rev Forecast
$18.32B
2026 Rev Forecast
$19.31B
2027 Rev Forecast
$18.08B
2028 Rev Forecast
$17.88B
2029 Rev Forecast
$18.05B
2030 Rev Forecast
$18.47B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$48.99 Buy/Sell $58.15 12.27%
REGN Stock Forecast Regeneron Pharmaceuticals Outperform 2
$907.32 Buy/Sell $961.26 15.73%
ZTS Stock Forecast Zoetis Outperform 18
$149.56 Buy/Sell $220.47 47.77%

Baxter International Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Baxter International Inc's Dividend per Share has grown by 20.83%, rising from $0.96 to $1.16. For next year, analysts predict Dividend per Share of $1.39, which would mean an increase of 19.83%. Over the next seven years, experts predict that Baxter International Inc's Dividend per Share will grow at a rate of 62.15%.

2024 DPS Forecast
$1.39
2025 DPS Forecast
$1.72
2026 DPS Forecast
$1.92
2027 DPS Forecast
$1.29
2028 DPS Forecast
$1.67
2029 DPS Forecast
$1.76
2030 DPS Forecast
$1.88
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$146.07 Buy/Sell $245.24 47.19%
VTRS Stock Forecast Viatris Inc Hold 8
$11.36 Buy/Sell $11.73 5.63%
UTHR Stock Forecast United Therapeutics Outperform 12
$234.47 Buy/Sell $284.08 26.67%

Baxter International Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$2.55B
2025 FCF Forecast
$3.34B
2026 FCF Forecast
$3.29B
2027 FCF Forecast
$2.33B
2028 FCF Forecast
$2.48B
2029 FCF Forecast
$2.78B
2030 FCF Forecast
$3.01B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CTLT Stock Forecast Catalent Hold 15
$56.03 Buy/Sell $49.29 13.33%
CYTK Stock Forecast Cytokinetics Outperform 10
$65.57 Buy/Sell $87.92 43.36%
IONS Stock Forecast Ionis Pharmaceuticals Outperform 9
$41.84 Buy/Sell $55.60 43.88%

Baxter International Inc EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Baxter International Inc's EBITDA has grown, rising from $2.70B to $2.78B – a growth of 2.78%. In the next year, analysts believe that EBITDA will reach $4.34B – an increase of 56.46%. For the next seven years, the forecast is for EBITDA to grow by 72.27%.

2024 EBITDA Forecast
$4.34B
2025 EBITDA Forecast
$4.68B
2026 EBITDA Forecast
$5.06B
2027 EBITDA Forecast
$4.74B
2028 EBITDA Forecast
$4.61B
2029 EBITDA Forecast
$4.64B
2030 EBITDA Forecast
$4.78B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MDGL Stock Forecast Madrigal Pharmaceuticals Outperform 4
$218.38 Buy/Sell $315.92 78.59%
BCPC Stock Forecast Balchem Outperform 18
$145.07 Buy/Sell $145.00 12.36%
NEOG Stock Forecast Neogen Outperform 16
$12.31 Buy/Sell $37.00 38.10%

Baxter International Inc EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Baxter International Inc's EBIT has seen a drop from $1.88B to $1.51B – a 19.44% decrease. In the next year, analysts believe that EBIT will reach $3.69B – an increase of 144.12%. For the next seven years, experts predict that Baxter International Inc's EBIT will grow at a rate of 161.16%.

2024 EBIT Forecast
$3.69B
2025 EBIT Forecast
$4.00B
2026 EBIT Forecast
$4.35B
2027 EBIT Forecast
$3.33B
2028 EBIT Forecast
$3.49B
2029 EBIT Forecast
$3.70B
2030 EBIT Forecast
$3.95B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INDV Stock Forecast Indivior PLC Buy 14
£15.20 Buy/Sell £28.89 107.24%
CORT Stock Forecast Corcept Therapeutics Buy 16
$23.00 Buy/Sell $35.67 65.22%
IRWD Stock Forecast Ironwood Pharmaceuticals Buy 14
$8.31 Buy/Sell $17.83 104.57%

Baxter International Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Baxter International Inc has seen a decline in its EPS, from $3.09 to $0.00 – a 100.00% decrease. Next year, analysts are expecting EPS to reach $5.50 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$5.50
2025 EPS Forecast
$6.06
2026 EPS Forecast
$6.57
2027 EPS Forecast
$4.44
2028 EPS Forecast
$5.58
2029 EPS Forecast
$5.95
2030 EPS Forecast
$6.37
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TGTX Stock Forecast TG Therapeutics Outperform 9
$14.25 Buy/Sell $29.44 138.60%
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$40.91 Buy/Sell $69.00 51.55%
CPRX Stock Forecast Catalyst Pharmaceuticals Buy 16
$14.73 Buy/Sell $26.20 76.51%